CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-15 | Payson Norman Director | Sale | −800 | $60.86 | $49K | 747,256 |
| 2021-09-14 | Livingston Mark S. Chief Financial Officer | Shares withheld for taxes | −117 | $57.17 | $7K | 90,231 |
| 2021-09-09 | Payson Norman Director | Sale | −7,430 | $58.36 | $434K | 756,486 |
| 2021-09-09 | Payson Norman Director | Sale | −900 | $58.62 | $53K | 755,586 |
| 2021-09-08 | Payson Norman Director | Sale | −5,974 | $57.18 | $342K | 766,272 |
| 2021-09-08 | Payson Norman Director | Sale | −2,356 | $57.87 | $136K | 763,916 |
| 2021-09-03 | Schlanger David J Chief Executive Officer | Exercise or conversion | +50,000 | $0.91 | $46K | 50,000 |
| 2021-09-03 | Schlanger David J Chief Executive Officer | Sale | −900 | $55.63 | $50K | 49,100 |
| 2021-09-03 | Schlanger David J Chief Executive Officer | Sale | −15,152 | $56.58 | $857K | 33,948 |
| 2021-09-03 | Schlanger David J Chief Executive Officer | Sale | −33,948 | $57.48 | $2.0M | 0 |
| 2021-09-03 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −50,000 | 2,684,384 | ||
| 2021-09-02 | Schlanger David J Chief Executive Officer | Exercise or conversion | +50,000 | $0.91 | $46K | 50,000 |
| 2021-09-02 | Schlanger David J Chief Executive Officer | Sale | −13,800 | $56.00 | $773K | 36,200 |
| 2021-09-02 | Schlanger David J Chief Executive Officer | Sale | −36,200 | $56.37 | $2.0M | 0 |
| 2021-09-02 | Schlanger David J Chief Executive Officer | Exercise or conversion · Employee Stock Option (right to buy) | −50,000 | 2,734,384 | ||
| 2021-09-02 | Payson Norman Director | Sale | −5,958 | $56.11 | $334K | 774,618 |
| 2021-09-02 | Payson Norman Director | Sale | −2,372 | $56.50 | $134K | 772,246 |
| 2021-09-01 | Schlanger David J Chief Executive Officer | Exercise or conversion | +50,000 | $0.91 | $46K | 50,000 |
| 2021-09-01 | Schlanger David J Chief Executive Officer | Sale | +18,422 | $55.72 | $1.0M | 31,578 |
| 2021-09-01 | Schlanger David J Chief Executive Officer | Sale | −31,578 | $56.32 | $1.8M | 0 |
Page 71 of 77 · 1,524 trades